AUS
NZ
UK
CA
USA
IND
Highlights:
- Monogram Orthopedics is a robotic platform integrated with personalized implants.
- Over one million knee joints are replaced every year in the US, and Monogram is looking to transform this industry.
- Monogram Orthopedics is developing products to enable mass personalization of orthopedic implants
Texas-based Monogram Orthopedics often grabs investors' attention due to its distinctive technology-driven mission of revolutionizing orthopedic surgeries in future.
Monogram Orthopedics is a robotic platform integrated with personalized implants. According to the company, it is developing medical technologies to drive change in joint reconstruction.
The Texas-based company is developing products to enable mass personalization of orthopaedic implants and is looking to integrate 3D printing and robotics.
According to Monogram Orthopedics, the integration could be achieved through digital image analysis algorithms. The company is looking to build a surgical robot that could instill confidence in surgeons that they can install implants that fit every patient.
Also Read: What is Neuralink & Why Is This Elon Musk-Founded Firm Trending?
The knee joint industry appears to have a high potential in the United States market. It is probably due to this reason that investors often search for Monogram Orthopedics stock.
Can you buy Monogram Orthopedics stock?
Yes, you can buy Monogram Orthopedics stock. However, it is essential to note that the company remains private, and its stock is not listed in a stock market.
It is uncertain if Monogram Orthopedics has an initial public offering (IPO) plan, but if you are interested in investing in this company, there is an option to do so.
©2022 Kalkine Media®
StartEngine, a platform where people can invest in startups and early-stage companies, provides access to preferred Monogram Orthopedics shares.
According to its website, Monogram Orthopedics has raised US$ 18.8 million by selling its preferred shares, and 11,661 people have invested in the company.
A preferred share of Monogram Orthopedic costs US$ 7.52 per share, and investors are required to make a minimum investment of US$ 250.8.
Notably, only one day is left to invest, and it appears that the window to buy preferred shares would close after that.
Bottom line
Monogram says it is yet to apply for the Food and Drugs Administration (FDA) approval. Until it gets approval from the FDA, the sales of Monogram's products may not commence.
As per the company website, more than one million knee joints are replaced every year in the US. Monogram is looking to transform this knee-joint replacement industry by offering customized implants.
